BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 17587816)

  • 1. Epithelial-mesenchymal transition in prostate cancer and the potential role of kallikrein serine proteases.
    Lawrence MG; Veveris-Lowe TL; Whitbread AK; Nicol DL; Clements JA
    Cells Tissues Organs; 2007; 185(1-3):111-5. PubMed ID: 17587816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kallikrein 4 (hK4) and prostate-specific antigen (PSA) are associated with the loss of E-cadherin and an epithelial-mesenchymal transition (EMT)-like effect in prostate cancer cells.
    Veveris-Lowe TL; Lawrence MG; Collard RL; Bui L; Herington AC; Nicol DL; Clements JA
    Endocr Relat Cancer; 2005 Sep; 12(3):631-43. PubMed ID: 16172196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of kallikrein-related peptidases in prostate cancer: potential involvement in an epithelial to mesenchymal transition.
    Whitbread AK; Veveris-Lowe TL; Lawrence MG; Nicol DL; Clements JA
    Biol Chem; 2006 Jun; 387(6):707-14. PubMed ID: 16800731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seminal fluid characterization for male fertility and prostate cancer: kallikrein-related serine proteases and whole proteome approaches.
    Veveris-Lowe TL; Kruger SJ; Walsh T; Gardiner RA; Clements JA
    Semin Thromb Hemost; 2007 Feb; 33(1):87-99. PubMed ID: 17253195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human kallikrein 7 induces epithelial-mesenchymal transition-like changes in prostate carcinoma cells: a role in prostate cancer invasion and progression.
    Mo L; Zhang J; Shi J; Xuan Q; Yang X; Qin M; Lee C; Klocker H; Li QQ; Mo Z
    Anticancer Res; 2010 Sep; 30(9):3413-20. PubMed ID: 20944116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Substrates of the prostate-specific serine protease prostase/KLK4 defined by positional-scanning peptide libraries.
    Matsumura M; Bhatt AS; Andress D; Clegg N; Takayama TK; Craik CS; Nelson PS
    Prostate; 2005 Jan; 62(1):1-13. PubMed ID: 15389820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polyclonal antibodies against kallikrein-related peptidase 4 (KLK4): immunohistochemical assessment of KLK4 expression in healthy tissues and prostate cancer.
    Seiz L; Kotzsch M; Grebenchtchikov NI; Geurts-Moespot AJ; Fuessel S; Goettig P; Gkazepis A; Wirth MP; Schmitt M; Lossnitzer A; Sweep FC; Magdolen V
    Biol Chem; 2010 Apr; 391(4):391-401. PubMed ID: 20180634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Signal transduction pathways involved in epithelial-mesenchymal transition in oral cancer compared with other cancers.
    Chang JY; Wright JM; Svoboda KK
    Cells Tissues Organs; 2007; 185(1-3):40-7. PubMed ID: 17587806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human kallikrein-related peptidase 12: antibody generation and immunohistochemical localization in prostatic tissues.
    Memari N; Diamandis EP; Earle T; Campbell A; Van Dekken H; Van der Kwast TH
    Prostate; 2007 Sep; 67(13):1465-74. PubMed ID: 17654496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kallikrein 4 is a proliferative factor that is overexpressed in prostate cancer.
    Klokk TI; Kilander A; Xi Z; Waehre H; Risberg B; Danielsen HE; Saatcioglu F
    Cancer Res; 2007 Jun; 67(11):5221-30. PubMed ID: 17545602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a novel complex between human kallikrein 2 and protease inhibitor-6 in prostate cancer tissue.
    Mikolajczyk SD; Millar LS; Marker KM; Rittenhouse HG; Wolfert RL; Marks LS; Charlesworth MC; Tindall DJ
    Cancer Res; 1999 Aug; 59(16):3927-30. PubMed ID: 10463585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear factor-kappaB-mediated transforming growth factor-beta-induced expression of vimentin is an independent predictor of biochemical recurrence after radical prostatectomy.
    Zhang Q; Helfand BT; Jang TL; Zhu LJ; Chen L; Yang XJ; Kozlowski J; Smith N; Kundu SD; Yang G; Raji AA; Javonovic B; Pins M; Lindholm P; Guo Y; Catalona WJ; Lee C
    Clin Cancer Res; 2009 May; 15(10):3557-67. PubMed ID: 19447876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct progesterone receptor and indirect androgen receptor interactions with the kallikrein-related peptidase 4 gene promoter in breast and prostate cancer.
    Lai J; Myers SA; Lawrence MG; Odorico DM; Clements JA
    Mol Cancer Res; 2009 Jan; 7(1):129-41. PubMed ID: 19147544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kallikrein 4 is a potential mediator of cellular interactions between cancer cells and osteoblasts in metastatic prostate cancer.
    Gao J; Collard RL; Bui L; Herington AC; Nicol DL; Clements JA
    Prostate; 2007 Mar; 67(4):348-60. PubMed ID: 17221837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compartmentalized expression of kallikrein 4 (KLK4/hK4) isoforms in prostate cancer: nuclear, cytoplasmic and secreted forms.
    Dong Y; Bui LT; Odorico DM; Tan OL; Myers SA; Samaratunga H; Gardiner RA; Clements JA
    Endocr Relat Cancer; 2005 Dec; 12(4):875-89. PubMed ID: 16322328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate cancer metastasis: role of the host microenvironment in promoting epithelial to mesenchymal transition and increased bone and adrenal gland metastasis.
    Xu J; Wang R; Xie ZH; Odero-Marah V; Pathak S; Multani A; Chung LW; Zhau HE
    Prostate; 2006 Nov; 66(15):1664-73. PubMed ID: 16902972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression analysis and prognostic significance of human kallikrein 11 in prostate cancer.
    Stavropoulou P; Gregorakis AK; Plebani M; Scorilas A
    Clin Chim Acta; 2005 Jul; 357(2):190-5. PubMed ID: 15893744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of peptides specifically modulating the activity of KLK2 and KLK3.
    Koistinen H; Närvänen A; Pakkala M; Hekim C; Mattsson JM; Zhu L; Laakkonen P; Stenman UH
    Biol Chem; 2008 Jun; 389(6):633-42. PubMed ID: 18627344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-thrombin is expressed in the benign prostatic epithelium and in prostate cancer and is capable of forming complexes with prostate-specific antigen and human glandular kallikrein 2.
    Cao Y; Lundwall A; Gadaleanu V; Lilja H; Bjartell A
    Am J Pathol; 2002 Dec; 161(6):2053-63. PubMed ID: 12466122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of TMPRSS4 during cancer progression.
    Choi SY; Shin HC; Kim SY; Park YW
    Drug News Perspect; 2008 Oct; 21(8):417-23. PubMed ID: 19034347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.